DALLAS--(BUSINESS WIRE)--Arthur Bollon, PhD, Chairman and Chief Executive Officer of HemoBioTech, Inc. (OTCBB: HMBT, http://www.hemobiotech.com), will be presenting at the MedTech Insight In3 Conference “Investment in Innovation West (In3): A Preview of Early- and Late-Stage Medical Technology Companies.” At the event, held February 28, 2008 at 4:30PM PST in Las Vegas, Nevada, Dr. Bollon will present the overall company strategy and discuss HemoTech, which is being developed as a viable substitute for human blood.
